Northwest Biotherapeutics

Northwest Biotherapeutics
NorthWest Biotherapeutics (NWBT)
Type Public (Nasdaq: [1])
Industry Pharmaceuticals
Headquarters Bothell, Washington
Products DCVax Brain
DCVax Prostate
See more complete products listing.
Website www.nwbio.com

Northwest Biotherapeutics is an American pharmaceutical company that focuses on developing immunotherapies against different types of cancer.

Contents

Mission

NWBT's stated goals stress product quality and purity, innovation, and efficient production.[2]

Technology

The DCVax technology upon which NWBT's therapies rely involves injecting cancer patients with dendritic cells, which contain high levels of the same antigens found in tumor cells. The immune system, alerted by these antigens, attacks the cancer as well as the injected cells.

Products

DCVax Brain is set to be distributed at select centers in Switzerland by September 2007.[1] DCVax Prostate has also been approved by the FDA for trials.[3]

Footnotes and references

External links

NWBT NASDAQ{{{1}}}